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Abstract The KH module has recently been identified in a num- 
ber of RNA associated proteins including vigilin and FMR1, a 
protein implicated in the fragile X syndrome. In this work, NMR 
spectroscopy was used to determine the secondary structure in 
solution of a KH domain (repeat 5 from vigilin). Almost complete 
assignments were obtained for the ~H and ~SN resonances using 
uniform ~SN-labeling of the protein combined with homo-nuclear 
2D ~HNMR and 3D lSN correlated ~H NMR. On the basis of 
NOE patterns, secondary chemical shifts and amide solvent expo- 
sure, the secondary structure consists of an antiparallel three 
stranded fl sheet connected by two helical regions. This domain 
may also be stabilized by an appended C-terminal helix which is 
common to many but not all members of the KH family. 
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I. Introduction 
The recently described KH domain (for hnRNP-K homolo- 
gous domain) [1,2] is one of four motifs (RNP, dsRBD, RGG/  
RGY and KH) which frequently recur in proteins associated 
with RNA,  often in multiple copies (for a review see [3]). 
FMR1, which contains two KH domains [4,5] is of particular 
interest since mutations of the gene cause fragile X syndrome, 
the most frequent cause of mental retardation in humans, af- 
fecting 1 in 1250 males and 30% of female carriers [6-8]. The 
KH domain is sometimes present in large numbers: 8 in yeast 
scpl60 and 14 in vigilin, the highest number so far [9,10]. Sev- 
eral KH-containing proteins are known to bind to RNA in vitro 
or were isolated from RNP complexes. 
The determination of the 3D structure of the KH motif  
would greatly benefit biochemical studies on whether and how 
it binds to RNA and inspire experiments to elucidate the func- 
tional role of the proteins containing this domain. A secondary 
structure prediction based on a multiple alignment has sug- 
gested that the KH motif  might form an independently folded 
unit. Sequence periodicity suggests an c~fl structure with a three 
stranded sheet connected by either one or two s-helices. As a 
first step towards the elucidation of the 3D structure of the KH 
module, we have produced genetically engineered fragments 
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containing the KH moti f  and examined them by NMR spec- 
troscopy. The sequence was selected from vigilin which has a 
particularly clear subunit structure making it especially suitable 
for the selection of individual domains and for studying the 
precise definition of the domain boundaries [10]. Almost full 
sequential assignment was achieved for one of the fragments, 
revealing the secondary structure of the KH domain. 
2. Materials and methods 
2.1. Expression and purification 
The DNA sequences corresponding to the KH domain containing 
fragments of human vigilin [11] in Fig. 1 were PCR-amplified with 
engineered Ncol and KpnI cloning sites respectively on 5' and 3' ends 
and then cloned into the NcoI and KpnI sites of a pET9d derivative. 
These constructs were expressed in E. coli strain BL21 (DE3) and the 
proteins were induced 3 h in a 101 culture by addition of 0.2 mM IPTG 
after the culture had reached an OD of 0.8 at 600 nm. 
Purification of the construct used for the NMR work was achieved 
as follows. The pellet was resuspended in 100 ml of 3 mM MgC12, 0.1 
mM PMSF, 10 mM Tris pH 8.5, 0.1 mg/ml DNase. Cells were lysated 
by French press and centrifuged. The supernatant was loaded on Q- 
Sepharose and SP-Sepharose columns connected in series and equili- 
brated with buffer A (10 mM Tris pH 8.5, 0.1 mM PMSF). A washing 
step of 50 ml buffer A allowed most bacterial proteins to be retained 
on the Q-Sepharose column, while the KH domain (calculated isoelec- 
tric point 9.93) was only retained on the SP-Sepharose. After removing 
the Q-Sepharose column, the SP-Sepharose column was developed with 
a NaC1 gradient from 0 to 600 mM. The KH domain waseluted at 300 
mM NaC1. The fractions containing the domain were concentrated and 
loaded on a Sephacryl S-200 superfine gel-filtration column equili- 
brated with 20 mM Tris, pH 8.0, 50 mM NaC1. The protein was finally 
dialysed against 5 mM KC1, pH 7.5, and concentrated. Uniformly ~SN- 
labeled samples were obtained from bacteria grown in M9 medium with 
15NHaCI as the sole nitrogen source. 
2.2. Nuclear magnetic resonance 
The NMR measurements were carried out on a BRUKER AMX- 
600 using 0.5-1 mM samples in 90% H20/10% D20 or in D20 at pH 
7.0-7.5, 5 mM KCI. 2D NMR spectra were acquired between 290 and 
308 K in phase sensitive mode (TPPI). Water suppression was achieved 
either with WATERGATE [12] or, for hetero-nuclear experiments, 
with the pulse-sequence suggested by Stonehouse etal. [13]. 2D and 3D 
TOCSY spectra were acquired using the TOWNY composite pulse 
cycle [14]. Mixing times used were in the 35-65 ms range for the 
TOWNY and 80-180 ms for the NOESY experiments. 2048 and 512 
data points in the acquisition domain and in fi, respectively, were used 
for all the 2D experiments. In the 3D experiment, spectral widths were 
set to 8065, 1946 and 8065 Hz and a matrix of 180, 112, 1024 points 
in the F1, F2 and F3 dimensions respectively was acquired and succes- 
sively zero-filled and fourier transformed to a 256 x 256 x 256 points 
matrix. Since the solubility of the sample after lyophilization decrease 
drastically, the degree of exposure of the amides was estimated from 
solvent saturation experiments. Two HSQC were performed in the 
absence and in the presence of water presaturation using the same 
receiver gain (the water was suppressed anyway by gradients either 
according to [12] or [13]). Peaks were integrated by the UXNMR 
software and they were considered protected when the percentage ratio 
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of the values obtained in the presence and in the absence of solvent 
saturation was higher then 50% normalized on the least affected peak. 
3. Resul ts  
3.1. Choice of the domain boundaries 
Inspection of known KH-containing sequences showed that 
in most of them the KH is preceded and followed by a stretch 
of about 18 residues with strong helical periodicity which links 
together contiguous KH motifs (see Fig. 1). This pattern is 
particularly clear for vigilin and the SCP160 protein [9]. We 
therefore selected one of the vigilin repeats (repeat 5). Of this, 
five constructs with different boundary choice were expressed 
but showed different behaviours (Fig. 1). Preliminary 1 D NMR 
experiments howed that constructs I, III and IV are stably 
folded, the appearance of the spectra being almost superimpos- 
able for most of  the resonances. Most of the further studies 
were then carried out on construct III, which was the best 
behaved. 
3.2. NMR assignment 
Optimal conditions for solubility and lack of aggregation 
were found for construct III around pH 7 and at low salt 
concentration. The protein aggregates at pH below 6, while it 
unfolds irreversibly at pH 4. The spectra recorded under neu- 
tral conditions showed very good intrinsic resolution which 
significantly helped full spectral assignment. Overlap was also 
reduced by collecting spectra at different emperature and by 
a 3D SQC-TOCSY experiment which confirmed the conclu- 
sions already obtained by 2D experiments. The assignment was 
obtained by standard assignment procedures [15]. The identifi- 
cation of two of the three alanines (67 and 75), of the valines 
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Fig. 1. Schematic representation f the vigilin architecture: ovals indi- 
cate the KH motifs, linkers represent putative s-helical regions [10]. The 
five constructs expressed are indicated below. Numbers on the con- 
structs refer to the corresponding amino acid positions in the complete 
vigilin sequence from human. For simplicity the numbering adopted in 
the text refers to the starting of construct III so that for instance Asn-7 
corresponds to Asn-434 of the complete sequence. The sequence of 
construct I is explicitly shown: the sequence of the KH module is 
indicated in roman letters, while those of the flanking putative helices 
are in italics. 
Table 1 
Chemical shifts in ppm of the assigned ~H NMR resonances of the KH module at 600 MHz and 27°C 
~SN HN C~H CflH C~,H Ct~H Others 
8.02 4.00 1.80 0.75 
8.32 4.20 
8.31 4.47 2.62 2.47 
8.15 4.20 1.55 0.81 0.75 
7.97 4.00 1.80 1.10 0.75 
8.40 4.60 2.75 2.62 6.90 7.73 
119.87 8.20 4.25 2.20 1.93 
119.25 8.27 4.51 2.53 2.39 1.92 
120.75 8.63 4.81 2.62 2.40 
114.75 7.89 5.51 2.81 6.76 6.61 
117.00 8.78 4.23 1.78 0.71 0.63 
122.00 8.38 5.25 185 1.78 2.21 1.97 
117.25 8.87 4.52 1.65 0.84 0.75 0.64 
120.75 8.47 5.20 2.63 2.43 7.24 6.77 
123.25 8.72 4.20 1.53 1.30 1.00 0.65 
126.80 8.85 4.06 2.56 
7.60 3.98 3.05 
Val-2 
Lys-3 
Asp-4 
Leu-5 
Ile-6 
Asn-7 
Arg-8 
Met-9 
Asp-10 
Tyr-11 
Val-12 
Glu-13 
Ile-14 
Asn-15 
Ile-16 
Asp-17 
His-18 
Lys-19 
Phe-20 
His-21 
Arg-22 
His-23 
Leu-24 
I1e-25 
Gly-26 
Lys-27 
Ser-28 
Gly-29 
Ala-30 
115.50 8.27 4.65 3.31 2.91 
117.90 7.97 4.15 3.13 2.94 
115.50 8.49 3.99 1.74 1.65 
7.75 4.41 3.15 3.06 
117.12 7.80 3.86 1.82 
112.62 7.45 3.69 1.81 
105.37 7.59 3.90 
119.62 7.80 4.15 3.75 
106.50 7.80 3.94 3.65 
(7.90) 4.03 1.40 
1.29 0.73 
1.05 0.93 
7.18 
7.97 6.37 
7.70 6.92 
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'SN HN C~H CflH CzH C6H Others 
Asn-31 121.50 8.07 4.55 2.83 2.56 7.57 7.02 
I1e-32 117.50 7.68 3.77 1.97 0.86 0.63 
Asn-33 118.75 8.21 4.33 2.78 2.69 7.49 6.82 
Arg-34 119.12 7.54 4.05 2.04 1.84 3.05 
Ile-35 119.00 7.69 3.46 1.87 1.05 0.68 
Lys-36 117.12 8.17 4.01 1.88 1.68 1.50 
Asp-37 116.37 7.75 4.34 2.64 2.54 
Gln-38 116.87 8.54 3.73 1.67 1.09 1.82 1.45 
Tyr-39 112.00 7.60 4.69 3.23 2.52 
Lys-40 116.00 7.72 4.10 2.18 182 1.28 
Val-41 107.62 7.31 5.06 1.95 0.54 0.45 
Ser-42 114.00 8.94 4.59 3.67 
Val-43 7.93 4.59 1.71 0.65 0.57 
Arg-44 127.25 9.12 4.48 1.64 1.48 1.23 2.89 
I1e-45 128.12 8.50 4.37 1.70 1.31 0.54 0.75 
Pro-46 - 4.05 2.22 2.06 3.53 3.99 
Pro-47 - 4.48 2.45 2.00 1.91 3.60 3.70 
Asp-48 (8.20) (4.48) 2.60 2.48 
Ser-49 4.31 4.02 3.85 
Glu-50 (8.47) 4.20 2.25 1.61 
Lys-51 119.75 (7.59) (4.00) (2.19 2.15) 2.00 
Ser-52 112.00 8.45 4.50 3.73 3.46 
Asn-53 120.87 8.43 4.97 2.95 2.63 7.46 6.90 
Leu-54 119.50 7.69 4.61 1.56 1.34 0.73 0.65 
I1e-55 124.12 8.84 4.31 1.53 1.32 0.82 0.45 0.24 
Arg-56 124.37 7.58 5.14 1.62 1.49 1.35 2.87 2.98 
Ile-57 125.75 8.94 4.91 1.59 1.39 0.54 0.75 0.63 
Glu-58 122.50 8.50 5.34 1.96 1.86 2.13 
Gly-59 108.75 8.35 4.46 3.92 
Asp-60 122.50 8.15 4.78 2.83 2.62 
Pro-61 - - 4.41 1.85 1.05 3.73 3.95 
Gln-62 115.12 8.17 4.05 2.04 2.30 (1.88) 
Gly-63 109.62 8.45 4.03 3.73 
Val-64 118.12 8.60 3.22 1.86 0.62 0.54 
Gln-65 114.37 7.12 3.76 1.95 2.03 2.37 
Gln-66 117.75 7.47 3.73 1.29 2.21 2.12 
Ala-67 119.75 8.25 3.46 1.07 
Lys-68 115.75 8.00 3.41 1.79 1.07 1.59 1.37 2.81 2.73 
Arg-69 115.37 7.12 3.78 1.82 1.75 1.60 1.41 3.07 
Glu-70 116.12 7.67 3.88 2.12 2.05 2.41 
Leu-71 117.87 8.32 3.85 2.63 1.35 1.47 0.85 0.42 
Leu-72 114.87 7.84 3.87 1.76 1.29 0.74 0.62 
Glu-73 117.37 7.66 3.92 2.12 1.99 2.35 
Leu-74 118.00 7.59 4.09 1.84 1.38 0.77 
Ala-75 119.87 7.25 3.96 1.08 
Ser-76 118.25 7.18 3.97 3.69 
6.87 6.69 
7.06 6.59 
7.64 6.68 
7.35 6.80 
Tentative assignments are given in parentheses. ~H spectra t 300K were referred to the water resonance at 4.69 ppm. 
and of the AMX systems was achieved immediately from 2D 
TOCSY patterns. The aromatic rings of  the two tyrosines (Tyr- 
11 and -39) could be easily connected to their amide protons 
by NOESY connectivities. The resonances of the aromatic pro- 
tons of Phe-20 were equivalent and could be identified only 
after examination of spectra in D20 and from an ~SN-SQC 
experiment. Pro-46, Pro-47 and Pro-61 were identified as trans 
residues from the presence of typical NOESY peaks between 
their 8 protons and the a protons of I1e-45, Pro-46 and Asp-60 
respectively [15]. In the fingerprint region below 4.5 ppm, 
strong sequential peaks connected with well isolated peaks 
which could then be identified easily (Fig. 2). Sequential HN-  
HN connectivities could be followed in the amide region with 
almost no overlap. Several independent entrance points helped 
in placing these connectivities along the sequence. 
Both hetero and homo-nuclear spectra showed, in addition 
to well defined and dispersed peaks, a few broad resonances 
with poor transfer. Some of these resonances could be assigned 
to the flexible N-terminus (from Val-2 to Asn-7) by comparing 
the two N-deleted constructs which differed by the presence of 
the first six residues (construct III and IV). Six residues (Lys-27, 
Ala-30, Asp-48, Ser-49, Glu-50 and Lys-51) could not be iden- 
tified from the amide region both in TOCSY and in NOESY 
experiments, even at very long mixing times. Since they are in 
unstructured loop regions, their amide protons are subjected to 
significant loss of sensitivity, which is especially high at neutral 
pH. This effect could be reduced but not cancelled using pulse 
field gradient techniques [12,13]. Ala-30, Ser-49 and Glu-50 
could however be observed from their c~ protons in the TOCSY 
and tentatively assigned. The spectral assignment is summa- 
rized in Table 1. 
3.3. Identification of the secondary structure 
Several resonances below 4.7 ppm and a number of sequen- 
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Fig. 2. NOESY spectrum at 300K and 600 MHz of a 1 mM solution 
sample of repeat 5 of vigilin at pH 7.0. Both the amide/amide and the 
fingerprint regions are shown. The numbers indicated correspond to 
thesequential amide/amide connectivities of H2 and H3 (lower plot) and 
to long-range HA/HN connectivities in the fl-sheet. 
tial amide/amide NOESY connectivities suggest immediately 
the presence of eft structure. Strong sequential H~,HN(i, i  + 1) 
NOESY connectivities as well as long-range backbone connec- 
tivities (see Fig. 3a and b) showed the presence of a three- 
stranded fl sheet involving residues Met-9 to Ile-16, Tyr-39 to 
Leu-45 and Asn-53 to Asp-60. The arrangement of the three 
strands is antiparallel with the first and the second strands 
flanking the last one. In addition, three helical stretches are 
present as shown by sequential HN-HN( i , i+  1), HA- 
HN(i,i + 3) and (i,i + 4) connectivities: a very short and flexible 
helix-like region between residue His-21 and Gly-26 (designated 
HI )  and a well defined helix spanning Asn-31 to Gln-38 (desig- 
nated H2) which is connected to the third ,6 strand by a type 
II fl turn. The last helix extends from Gln-62 to Leu-74 and 
spans the C-terminal linker (designated H3) (Fig. 3c). The seven 
N-terminal residues and the region between Lys-19 and His-23 
are flexible in solution, as shown by the significantly reduced 
NOE intensities. The C-terminal region is, by contrast, very 
well structured until the end. The protection of amide protons 
measured by solvent saturation transfer experiments shows a 
very good correlation with the secondary structure elements 
(Fig. 3a). In particular, amides in the region 54-60 are generally 
more protected than those in the external fl-strands. Finally, a 
plot of the secondary chemical shifts vs. the sequence shows 
three negative and three positive regions fully consistent with 
the presence of the three helices and strands (Fig. 3a). 
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Fig. 3. (a) Survey of the NOE effects observed. In italics is the secondary 
structure prediction as obtained from the PredictProtein EMBL e-mail 
server [23] is reported together with the degree of confidence. The main 
classes of short range contacts observed are shown together with the 
secondary chemical shifts (SCS) and protons which are solvent inacces- 
sible in solvent saturation transfer experiments (UP). A window of + 2 
points was used to smooth the SCS data. (b) The three-strandedfl-sheet 
of the KH. Continuous lines identify observed interstrand NOEs. A 
dotted line between Ile-14 and Ile-55 indicates that this effect could not 
be observed because these two amides are coincident. (c) Schematic 
representation f the secondary structure of the KH domain in the same 
orientation as in b. 
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Fig. 3 (continued). 
3.4. Three-dimensional arrangement 
In addition to the long-range ffects which identify the pres- 
ence of a fl-sheet, other connectivities were observed even at an 
early stage of the structure determination. The aromatic ring 
of His-21 is surrounded by Ile-55 (the 6 protons of which are 
ring current shifted to 0.22 ppm), Pro-46 and Asn-43. The 
aliphatic protons of I1e-45 and Ile-55 also show clear connectiv- 
ities. These effects help in placing the H1 approximately per- 
pendicularly to the fl-sheet (Fig. 3c). The presence of two con- 
served hydrophobic residues in H2 (Ile-32 and -35) suggests 
that they pack into the fl sheet but no NOEs were observed so 
far because of overlap. Preliminary analysis of the NOESY 
data suggests that in our construct he C-terminal helix folds 
back and packs into the KH. However, the role of these helices 
remains perplexing since a survey of the sequence databases 
shows that all the proteins containing helix-KH-helix repeats 
contain n + 1 helices if n is the number of KH domains. In 
addition to vigilin (where there are 15 helices but only 14 KH 
domains) and yeast Scpl60 (with 9 helices but 8 KH domains), 
the family includes hnRNP K [3]; hnRNP E1 (accession o. 
X78137); Nova-1 [16]; FBP [17]; and three C. elegans cosmid 
reading frames, C06G4.1, M88.5 and Zk418.9 [18]. However, 
each KH domain appears most closely associated with the 
C-terminal helix: there is almost never an insertion in the loop 
connecting the third KH strand and the following helix, 
whereas large insertions are tolerated between the preceding 
N-terminal helix and the first fl-strand of the KH domain. 
4. Discussion 
The work described here shows that the KH motif folds into 
a stable ~/~ structure consisting of a three-stranded sheet and 
two helices, the first of which has high flexibility, in excellent 
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agreement with secondary structure predictions ([2] and Fig. 
3a). The KH domain sequence alignment shows no absolutely 
conserved residues, although there is a preference for positively 
charged residues in the region encompassing the two KH he- 
lices and the connecting loop. Thus these residues will cluster 
to one face of the KH domain, suggesting a surface for interac- 
tion with RNA. The flexible H1 has the highest density of 
semi-conserved charge (e.g. five in vigilin repeat-5). In some 
other nucleic acid binding domains, such as the bZIP proteins 
[19] and the U1A RNP domain [20], flexible regions in the 
unbound domain acquire a stable fold induced by binding nu- 
cleic acid. By analogy with such proteins, we suggest hat the 
behaviour in solution of the region around H 1 will be lost upon 
RNA-binding. 
Most fragile X lesions are caused by amplified triplet repeats 
which completely shut down FMR 1 gene expression. However, 
in one documented case with an aggravated phenotype, the 
FMR 1 protein is expressed but carries a point mutation, Ile- 
304~Asn,  in the second KH domain at a conserved 
hydrophobic position [21,22]. This amino acid, equivalent to 
Ile-32 in construct III, is in the second helix of the KH and 
shows a very high protection factor from solvent saturation 
transfer experiments. Therefore, the mutation of this residue is 
likely to destabilize the KH domain structure. 
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